Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CIPHER DIGITAL INC. (CIFR)

  • Business News
  • May 05, 2026, 11:22 UTC
  • 4
  • 1 comments

Cipher Digital Provides First Quarter 2026 Business Update

Market reaction Comment Full text

Avanos Medical Inc (AVNS)

  • Business News
  • May 05, 2026, 11:21 UTC
  • 4
  • 1 comments

New SEC Filing for Avanos Medical Inc. (NYSE:AVNS)

Market reaction Comment Full text

ARCELORMITTAL (MT)

  • Business News
  • May 05, 2026, 11:21 UTC
  • 3
  • 1 comments

ArcelorMittal announces results of its General Meetings

Market reaction Comment Full text

TRANSDIGM GROUP INC (TDG)

  • Business News
  • May 05, 2026, 11:15 UTC
  • 3
  • 1 comments

TransDigm Group Reports Fiscal 2026 Second Quarter Results USA - English USA - English

Market reaction Comment Full text

SOW GOOD INC. (SOWG)

  • Business News
  • May 05, 2026, 11:15 UTC
  • 3
  • 1 comments

Sow Good Secures $20 Million Non-Convertible Private Placement Credit Facility to Fund Critical Minerals Strategy

Market reaction Comment Full text

HUNTINGTON INGALLS INDUSTRIES, INC. (HII)

  • Business News
  • May 05, 2026, 11:15 UTC
  • 3
  • 1 comments

HII Reports First Quarter 2026 Results

Market reaction Comment Full text

TURPAZ INDUSTRIES LTD (TRPZ)

  • Business News
  • May 05, 2026, 11:14 UTC
  • 3
  • 1 comments

Register of shareholders, changes and share capital status - exercise of warrants by employees

Market reaction Comment Full text

Cellectar Biosciences Inc. (CLRB)

  • Business News
  • May 05, 2026, 11:10 UTC
  • 3
  • 1 comments

Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia

Market reaction Comment Full text

CELLECTAR BIOSCIENCES, INC. (CLRB)

  • Business News
  • May 05, 2026, 11:10 UTC
  • 3
  • 1 comments

Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia

Market reaction Comment Full text

BLOCKMATE VENTURES INC. (TEL)

  • Business News
  • May 05, 2026, 11:07 UTC
  • 3
  • 1 comments

Telenor oppretter nasjonalt sky-selskap

Market reaction Comment Full text
  • Previous
  • 358
  • 359
  • 360
  • 361
  • 362
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158491)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin